Clinical efficacy of sacubitril valsartan sodium combinedwith metoprolol sustained-release tablets in thetreatment of refractory heart failure

LIU Shihong; SANG Shudong

doi:10.7619/jcmp.201913003

Journal of Clinical Medicine in Practice > 2019 > 23(13): 10-13, 17. > DOI: 10.7619/jcmp.201913003

LIU Shihong, SANG Shudong. Clinical efficacy of sacubitril valsartan sodium combinedwith metoprolol sustained-release tablets in thetreatment of refractory heart failure[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 10-13, 17. DOI: 10.7619/jcmp.201913003

Citation:

PDF (766 KB)

Clinical efficacy of sacubitril valsartan sodium combinedwith metoprolol sustained-release tablets in thetreatment of refractory heart failure

LIU Shihong,
SANG Shudong^,

Department of Cardiovasology, East Division of First Affiliated Hospital of Xi′an Jiaotong University, Xi′an, Shaanxi, 710089

More Information

Received Date: May 04, 2019
Accepted Date: June 07, 2019
Available Online: February 23, 2021
Published Date: July 14, 2019

Graphical Abstract

Abstract

Abstract

Objective To investigate the clinical effect of sacubitril valsartan sodium combined with metoprolol sustained-release tablets in the treatment of refractory heart failure.
Methods A total of 159 patients with refractory heart failure in our hospital were divided into combination group (n=80) and reference group (n=79) according to the treatment plan. The original treatment plan was re-examined, and the combined anti-heart failure treatment was applied. The reference group was added with metoprolol sustained-release tablets, and the combined group was combined with sacubitril valsartan sodium and metoprolol sustained-release tablets. Clinical efficacy, adverse reactions and cardiac function [left ventricular ejection fraction (LVEF), stroke volume (SV), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD)], serum intercellular adhesion molecule-1 (ICAM-1), N-terminal B-type brain natriuretic peptide (NT-proBNP), aldosterone (ALD) levels, Minnesota Living with Heart Failure Questionnaire(MLHFQ) scores were compared between the two groupsbefore treatment and after 8-week treatment.
Results The total effective rate of the combined group was higher than that of the reference group[88.75% (71/80) vs. 73.42% (58/79), P < 0.05]. The serum ICAM-1, NT-proBNP, ALD level of the combined group after 8 weeks of treatment were lower than that of the reference group (P < 0.05); after 8 weeks of treatment, LVESD and LVEDD were lower, and LVEF and SV were larger than that of the reference group (P < 0.05). After 8 weeks of treatment, the MLHFQ scores of both groups were significantly lower, and the combined group was lower than that of the reference group (P < 0.05). No intolerance occurred in the two groups, and the adverse reactions were mild, without any impact on the treatment. The incidence of adverse reactions in the combined group was 5.00% (4/80), and 3.90% (3/77) in the reference group, but there was no significant difference (P>0.05).
Conclusion sacubitril valsartan sodium combined with metoprolol sustained-release tablets is safe and effective in the treatment of refractory heart failure, which can further reduce serum ICAM-1, NT-proBNP, ALD levels, improve heart function and quality of life, and can not increase adverse reactions.
- sacubitril valsartan sodium,
- refractory heart failure,
- metoprolol sustained-release tablets,
- cardiac function,
- adverse reactions,
- aldosterone

FullText(HTML)

References (22)

References

[1]	刘陶萍, 唐逸, 唐国传. 顽固性心力衰竭的治疗进展[J]. 实用心脑肺血管病杂志, 2015, 23(1): 4-6. doi: 10.3969/j.issn.1008-5971.2015.01.002
[2]	陈文文, 刘燕琳, 李振山, 等. 沙库巴曲缬沙坦在心衰治疗中的应用: 从临床试验到真实世界[J]. 中国医院药学杂志, 2018, 38(21): 2286-2290. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ201821022.htm
[3]	Fröhlich H, Torres L, Täger T, et al. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure[J]. Clin Res Cardiol, 2017, 106(9): 711-721. doi: 10.1007/s00392-017-1115-0
[4]	Ponikowski P, Voors A A, Anker S D, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur J Heart Fail, 2016, 18(8): 891-975. doi: 10.1002/ejhf.592
[5]	茆金星, 张国虎, 徐元平, 等. 米力农联合多巴胺治疗老年顽固性心力衰竭的临床疗效及对心功能和N-末端B型利钠肽前体水平的影响[J]. 中国老年学杂志, 2016, 36(4): 815-816. doi: 10.3969/j.issn.1005-9202.2016.04.020
[6]	林琳, 唐农, 刘布谷, 等. 小剂量多巴胺联合米力农对顽固性心力衰竭的疗效及对心功能的影响[J]. 现代生物医学进展, 2017, 17(33): 6498-6501, 6522. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201733022.htm
[7]	Lage J G B, Gutierrez P S. Case 3/2017 - a 47-year-old female with refractory heart failure and embolic acute myocardial infarction[J]. Arq Bras Cardiol, 2017, 109(1): 81-86. http://pubmedcentralcanada.ca/pmcc/articles/PMC5524479/
[8]	王学影. 曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭患者的临床效果[J]. 中国医药导报, 2017, 14(2): 131-134. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201702030.htm
[9]	齐旭浩. 地高辛联合美托洛尔治疗心力衰竭的疗效[J]. 江苏医药, 2018, 44(3): 314-316. https://www.cnki.com.cn/Article/CJFDTOTAL-YIYA201803023.htm
[10]	徐燕. 美托洛尔对急性心肌梗死大鼠心肌损伤及c-fos信号通路的影响[J]. 中国现代医学杂志, 2018, 28(31): 7-13. doi: 10.3969/j.issn.1005-8982.2018.31.002
[11]	García-Prieto J, Villena-Gutiérrez R, Gómez M, et al. Neutrophil stunning by metoprolol reduces infarct size[J]. Nat Commun, 2017, 8: 14780. doi: 10.1038/ncomms14780
[12]	李宗卫. 西地兰联合美托洛尔治疗急性左心衰合并房颤临床效果分析[J]. 中西医结合心脑血管病杂志, 2017, 15(15): 1869-1871. doi: 10.3969/j.issn.1672-1349.2017.15.019
[13]	柯子立, 陈芬, 陈志强, 等. 琥珀酸美托洛尔缓释片与酒石酸美托洛尔片治疗慢性心力衰竭临床疗效的Meta分析[J]. 实用心脑肺血管病杂志, 2016, 24(9): 1-5. doi: 10.3969/j.issn.1008-5971.2016.09.001
[14]	罗功汶. 贝那普利联合美托洛尔对慢性心力衰竭患者心功能和生活质量的影响[J]. 现代中西医结合杂志, 2014, 23(25): 2771-2773. doi: 10.3969/j.issn.1008-8849.2014.25.014
[15]	董小伟, 王红雷, 来利红, 等. 沙库巴曲缬沙坦联合比索洛尔治疗慢性心力衰竭的临床研究[J]. 现代药物与临床, 2018, 33(11): 2791-2794. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW201811006.htm
[16]	Wang T D, Tan R S, Lee H Y, et al. Effects of Sacubitril/Valsartan (LCZ696) on natriuresis, diuresis, blood pressures, and NT-proBNP in salt-sensitive hypertension[J]. Hypertension, 2017, 69(1): 32-41. doi: 10.1161/HYPERTENSIONAHA.116.08484
[17]	魏云杰, 张密, 许海军, 等. 沙库巴曲缬沙坦治疗高龄射血分数降低心力衰竭患者的临床疗效研究[J]. 实用心脑肺血管病杂志, 2018, 26(7): 17-20. doi: 10.3969/j.issn.1008-5971.2018.07.004
[18]	McCormack P L. Sacubitril/Valsartan: A review in chronic heart failure with reduced ejection fraction[J]. Drugs, 2016, 76(3): 387-396. doi: 10.1007/s40265-016-0544-9
[19]	张薇琳, 周海英, 杨小明. 双效血管紧张素受体-脑啡肽酶抑制剂沙库巴曲/缬沙坦的研究进展[J]. 世界临床药物, 2017, 38(12): 851-854. https://www.cnki.com.cn/Article/CJFDTOTAL-GWHH201712016.htm
[20]	李春伟, 李轶鹏, 秦文艳, 等. 血清sCD40L联合NT-proBNP对心力衰竭的诊断及预后评估价值研究[J]. 中国实验诊断学, 2017, 21(5): 816-819. doi: 10.3969/j.issn.1007-4287.2017.05.016
[21]	王健, 曾庆宁, 周晓露, 等. 益气温阳活血利水方对慢性心力衰竭患者ICAM-1水平的影响[J]. 四川中医, 2017, 35(2): 76-78. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201702030.htm
[22]	王萌, 邢淑华, 常亚彬, 等. 动脉导管未闭患儿介入封堵术前后血清醛固酮变化与心肌重塑的关系[J]. 中国介入心脏病学杂志, 2018, 26(6): 336-340. doi: 10.3969/j.issn.1004-8812.2018.06.008

[1]	ZHANG Li, BAI Jing, YAN Jingxiao, WANG Haijie, ZHANG Yan. Application of transvaginal ultrasound, multimodal magnetic resonance imaging and ¹⁸F-fluorodeoxyglucose positron emission computed tomography/computed tomography in diagnosis of endometrial carcinoma[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 69-72, 77. DOI: 10.7619/jcmp.20243701
[2]	LI Xiaolu, HUO Liqun, GU Jun. Research progress on positron emission tomography/magnetic resonance imaging in diagnosis and treatment of breast cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(24): 115-119. DOI: 10.7619/jcmp.20231580
[3]	ZHANG Zhixiang, CUI Bo, LI Tianyun, XIE Fei. Multi-slice spiral computed tomography versus gadolinium diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging in follow-up of primary hepatic cancer after transcatheter hepatic arterial chemoembolization[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 9-13. DOI: 10.7619/jcmp.20222213
[4]	LI Juanjuan, LIU Min, YANG Bin, DU Wei, YANG Hongkai, LIAO Yanquan, LI Junhang, WANG Jun. Application of artificial intelligence-assisted pulmonary nodule screening and qualitative diagnosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 8-12. DOI: 10.7619/jcmp.20214698
[5]	ZHOU Chunshan, HUANG Yan, YAN Wenchao. Value of computed tomography scan versus magnetic resonance imaging in the diagnosis of pancreatic cystadenocarcinoma[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 47-50. DOI: 10.7619/jcmp.202020013
[6]	ZHAO Chenghua. Value of artificial intelligence assisted diagnostic system combined with CT test in diagnosis of pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 9-11. DOI: 10.7619/jcmp.202019003
[7]	HU Shanwen, WANG Lei, HOU Xiaoli, WANG Jigui, LUO Xinhui. CT versus MRI in diagnosis of early avascular necrosis of femoral head[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 40-43. DOI: 10.7619/jcmp.201907011
[8]	TIAN Juan, WANG Huifang, DONG Jianghua. Value of abdominal computed tomography in evaluating extramural vascular invasion of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 29-31, 36. DOI: 10.7619/jcmp.201907008
[9]	CHEN Jie, ZHANG Hao, TANG Zhiqi. Value of MRI combined with CT in diagnosis and assessment of spinal tuberculosis[J]. Journal of Clinical Medicine in Practice, 2018, (11): 104-105,108. DOI: 10.7619/jcmp.201811029
[10]	KAI Huihua, WANG Xiang, XUE Yuejun, ZOU Ping, ZHANG Chunhong, CAO Jian, PAN Changjie. Application of low-dose multi-slice spiral CT multi-stage scan and three-dimensional reconstruction in diagnosis of patients with gastric carcinoma[J]. Journal of Clinical Medicine in Practice, 2017, (5): 106-109. DOI: 10.7619/jcmp.201705029

Cited By

Get Citation

PDF

XML

Article views PDF downloads

Turn off MathJax

Article Contents

Abstract

References

Clinical efficacy of sacubitril valsartan sodium combinedwith metoprolol sustained-release tablets in thetreatment of refractory heart failure

Abstract

References

Related Articles

Catalog

Clinical efficacy of sacubitril valsartan sodium combinedwith metoprolol sustained-release tablets in thetreatment of refractory heart failure

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content